AAPM Member Participation in November IPRCC Meeting

On November 18, AAPM member Beth Darnall, PhD, participated in the NIH Interagency Pain Research Coordinating Committee meeting as an ad hoc committee member. The meeting was webcast and archived. 

Continue reading
Topics:
NIH

Interagency Pain Research Coordinating Committee Meeting - November 2019

The Interagency Pain Research Coordinating Committee will hold its next meeting on November 18, 2019, and will be available on a videocast. For more information.  
Topics:

NIH Study in Mice Explains How Brain Can Turn Pain Signals Up or Down

A new study in mice uncovered a previously unknown role that the central amygdala can play in upgrading or downgrading pain signals in the brain's circuitry. The study, published in Cell Reports , was conducted by resear...
Continue reading

AAPM Leaders Awarded NIH Heal Initiative Funds

The National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term (HEAL) Initiat...
Continue reading
Topics:
NIH

NIH to Investigate Minor Cannabinoids and Terpenes for Potential Pain-Relieving Properties

Nine new research awards totaling approximately $3 million will investigate the potential pain-relieving properties and mechanisms of actions of the diverse phytochemicals in cannabis, including both minor cannabinoids a...
Continue reading

Request for Information: Guidance on Current Education Curricula for Health Care Professionals Regarding Pain and Opioid Misuse and Use Disorder

NIH has issued a Request for Information to gather input from the scientific research and medical education communities and the general public regarding the Centers for Excellence in Pain Education (CoEPEs) program, gene...
Continue reading
Topics:
NIH

A Shot at Blocking Addiction

With the help of a NIH grant, University of New Mexico researchers are developing a vaccine that would block opioids from acting in the brain, a treatment that could play a key role in overcoming addiction. 

Continue reading
Topics:

NIH to Test Experimental Drug to Curb Opioid Cravings

A clinical trial of an experimental drug designed to treat cravings associated with OUD has begun in the National Institutes of Health Clinical Center. The Phase I trial in healthy adults will assess the safety of the experimental compound, ANS-6637, and how it is processed in the body when given with another drug that is processed by the same liver enzyme pathway. 

Continue reading
Topics:

AAPM member benefits include discounts on educational courses, products, and the Annual Meeting.

Learn More